Last update 21 Nov 2024

JNJ-70218902

Overview

Basic Info

Drug Type
Bispecific T-cell Engager (BiTE)
Synonyms
Target
CD3 x TMEFF2
Mechanism
CD3 stimulants(T cell surface glycoprotein CD3 stimulants), TMEFF2 inhibitors(Tomoregulin-2 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Janssen Research & Development LLC
Active Organization
Janssen Research & Development LLC
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with JNJ-70218902
NCT04397276 / Active, not recruitingPhase 1
A Phase 1 Study of JNJ-70218902, a T Cell Redirecting Agent, in Advanced Stage Solid Tumors
100 Clinical Results associated with JNJ-70218902
Login to view more data
100 Translational Medicine associated with JNJ-70218902
Login to view more data
100 Patents (Medical) associated with JNJ-70218902
Login to view more data
100 Deals associated with JNJ-70218902
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
CA
Janssen Research & Development LLC
10 Jul 2020
Advanced Malignant Solid NeoplasmPhase 1
ES
Janssen Research & Development LLC
10 Jul 2020
Advanced Malignant Solid NeoplasmPhase 1
IL
Janssen Research & Development LLC
10 Jul 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04397276 (ESMO2022)
ManualManual
Phase 1
Prostatic Cancer
73
(tqthnbhmcj) = wrvljybiwa qswqfcncej (agakzlebtr )
View more
Positive
10 Sep 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free